Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
63.363,22
1,11%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Nucryst Pharmaceuticals - Common Shares (MM) (NCST) Nucryst Pharmaceuticals - Common Shares (MM) (NCST) Notizie

NCST

Nucryst (NCST)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NCST
DataOraFonteTitoloSimboloCompagnia
08/02/201023:20Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NASDAQ:NCSTNucryst Pharmaceuticals - Common Shares (MM)
08/02/201020:13PR Newswire (US)NUCRYST Announces Completion of AmalgamationNASDAQ:NCST
15/01/201023:25Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NCSTNucryst Pharmaceuticals - Common Shares (MM)
15/01/201022:33PR Newswire (US)NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of ShareholdersNASDAQ:NCST
31/12/200920:00PR Newswire (US)NUCRYST Announces Further Adjournment of Special Shareholder MeetingNASDAQ:NCST
29/12/200922:54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NCSTNucryst Pharmaceuticals - Common Shares (MM)
22/12/200922:45PR Newswire (US)Smith & Nephew Completes Acquisition of the Assets of Nucryst Pharmaceuticals Corp.NASDAQ:NCST
22/12/200919:57PR Newswire (US)NUCRYST Announces the Completion of the Sale of its Acticoat BusinessNASDAQ:NCST
02/12/200918:35Edgar (US Regulatory)Statement of Ownership: Private Transaction (SC 13E3)NASDAQ:NCSTNucryst Pharmaceuticals - Common Shares (MM)
21/11/200900:18PR Newswire (US)NUCRYST Announces Special Meeting of ShareholdersNASDAQ:NCST
16/11/200912:04Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NCSTNucryst Pharmaceuticals - Common Shares (MM)
13/11/200922:47PR Newswire (US)NUCRYST announces 2009 third quarter financial resultsNASDAQ:NCST
11/11/200911:36Dow Jones NewsSmith & Nephew Buys Nucryst Pharma Assets For Initial $21 MillionNASDAQ:NCSTNucryst Pharmaceuticals - Common Shares (MM)
11/11/200901:15PR Newswire (US)NUCRYST Announces Agreement to Sell Acticoat Business and Proposes Amalgamation with WestaimNASDAQ:NCST
18/09/200923:11PR Newswire (US)NUCRYST Receives Deficiency Notice from NASDAQNASDAQ:NCST
03/09/200916:19PR Newswire (US)European Launch of Acticoat(TM) Flex with NUCRYST's Nanocrystalline Silver Technology Announced by Smith NephewNASDAQ:NCST
05/08/200913:00PR Newswire (US)NUCRYST announces 2009 second quarter financial resultsNASDAQ:NCST
29/07/200915:00PR Newswire (US)New ACTICOAT(TM) Silver Coated Anti-microbial Barrier Dressing Receives 510(k) Clearance from the US FDANASDAQ:NCST
21/07/200922:30PR Newswire (US)Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 Second Quarter ResultsNASDAQ:NCST
06/05/200913:00PR Newswire (US)NUCRYST announces 2009 first quarter financial resultsNASDAQ:NCST
29/04/200923:26PR Newswire (US)Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter ResultsNASDAQ:NCST
19/02/200912:03Edgar (US Regulatory)Annual Report (10-K)NASDAQ:NCSTNucryst Pharmaceuticals - Common Shares (MM)
17/02/200913:00PR Newswire (US)NUCRYST Announces Fourth Quarter and Year End 2008 Financial ResultsNASDAQ:NCST
12/02/200918:51PR Newswire (US)NUCRYST Approves $0.80 Per Share Cash Distribution to ShareholdersNASDAQ:NCST
19/01/200920:31PR Newswire (US)NUCRYST appoints interim CEONASDAQ:NCST
16/01/200914:00PR Newswire (US)NUCRYST Pharmaceuticals appoints a new directorNASDAQ:NCST
31/12/200817:59Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:NCSTNucryst Pharmaceuticals - Common Shares (MM)
19/12/200820:01PR Newswire (US)NUCRYST calls special meeting of shareholdersNASDAQ:NCST
11/12/200816:42Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:NCSTNucryst Pharmaceuticals - Common Shares (MM)
02/12/200815:46PR Newswire (US)NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority ShareholderNASDAQ:NCST
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NCST

La tua Cronologia

BIT
P21MU2
NLBNPIT21MU2 20240918 6000
TG
A288GE
OAT0 Pct 25FEB24
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network